Pharmaceutical Manufacturers Rapidly Adopt Authentication Formats
Pharmaceutical manufacturers pursuing authentication and track-and-trace compliance are increasingly specifying validated security bottles with documented band integrity and void-indication testing, rather than the conventional closure that dominated pharmaceutical packaging when authentication molding costs were less competitive in prior years. This shift commands meaningfully higher unit cost than conventional closure format given the enhanced testing and certification requirements involved. Converters report authentication orders now outpacing conventional orders across several major pharmaceutical brand accounts tracked this cycle, a clear reversal from just a few years earlier across comparable launches. overall. broadly. today. This ties directly to the security holograms market, which MMA forecasts will reach USD 5.99 billion by 2036 at a 6.5% CAGR.
Market Impact: Drives roughly 5% of demand








